4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-053498
President & CEO sold 100,000 shares at an average $17.37 ($1,737,090)
- President & CEO acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-10-15 | Option exercise | +33,333 | $7.21 | $240,331 | 346,108 | D: show line 1 in the form |
| ROBIN HOWARD W President & CEO | 2019-10-15 | Sale | −8,833 | $16.35 | $144,420 | 337,275 | D: show line 2 in the form |
| ROBIN HOWARD W President & CEO | 2019-10-15 | Sale | −24,500 | $17.17 | $420,665 | 312,775 | D: show line 3 in the form |
| ROBIN HOWARD W President & CEO | 2019-10-16 | Option exercise | +33,334 | $7.21 | $240,338 | 346,109 | D: show line 4 in the form |
| ROBIN HOWARD W President & CEO | 2019-10-16 | Sale | −33,334 | $17.48 | $582,678 | 312,775 | D: show line 5 in the form |
| ROBIN HOWARD W President & CEO | 2019-10-17 | Option exercise | +33,333 | $7.21 | $240,331 | 346,108 | D: show line 6 in the form |
| ROBIN HOWARD W President & CEO | 2019-10-17 | Sale | −33,333 | $17.68 | $589,327 | 312,775 | D: show line 7 in the form |
| Open-market sales · 100,000 sh · avg $17.37 · $1,737,090 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-10-15 | Option exercise · Stock Option | −33,333 | 66,667 | D: show line 8 in the form | |||||
| ROBIN HOWARD W President & CEO | 2019-10-16 | Option exercise · Stock Option | −33,334 | 33,333 | D: show line 9 in the form | |||||
| ROBIN HOWARD W President & CEO | 2019-10-17 | Option exercise · Stock Option | −33,333 | 0 | D: show line 10 in the form |
Loading xslF345X03/doc4.xml…